Cover art for MiniMed's Product Cycle Hides Split-Off Hangover

MiniMed's Product Cycle Hides Split-Off Hangover

MiniMed's split-off obscures product-cycle progress despite strong Q1 growth.

Nov 18, 2026

3 cards · 40s · tap to begin

From · · 40s

MiniMed's Product Cycle Hides Split-Off Hangover

MiniMed's split-off obscures product-cycle progress despite strong Q1 growth.

In brief

MiniMed's split-off obscures product-cycle progress despite strong Q1 growth. MiniMed Group's Q1 organic growth accelerated to 15.8% with new U.S. pump volumes rising over 20% as it shifts from share donor to share taker. Originally reported by Seekingalpha.

MiniMed Group

blood sugar and diabetes concept.

MiniMed Group's Q1 organic growth accelerated to 15.8% with new U.S. pump volumes rising over 20%.

Product Cycle Progress

Flex, the Fit patch pump, and Vivera could complete MiniMed's portfolio by late 2027 despite regulatory, competitive, and separation risks.

Share Taker Shift

MiniMed is priced at 1.43x forward EV/sales with potential recovery from easing split-off supply and improved cash conversion.

The big picture

MiniMed Group's Q1 organic growth accelerated to 15.8% with new U.S. pump volumes rising over 20% as it shifts from share donor to share taker.

Read the original on Seekingalpha

Read the TL;DR — this story on one card.

More news from the United States

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on minimed and related topics.